ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Everolimus Eluting Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-36P17346
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Everolimus Eluting Stent Market Research Report 2024
BUY CHAPTERS

Global Everolimus Eluting Stent Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-36P17346
Report
October 2025
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific
Abbott

Everolimus Eluting Stent Market

The global Everolimus Eluting Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Ivolimus drug eluting stents are typically composed of a metal scaffold and a drug coating covering the surface of the scaffold. Metal brackets are usually made of biocompatible materials, such as stainless steel, chromium cobalt alloy, etc. The drug coating of the stent contains Everolimus, an immunosuppressive drug. The drug will be released onto the vascular wall around the stent, thereby inhibiting intimal hyperplasia and reducing the risk of vascular restenosis. Ivolimus drug eluting stents work in two ways: metal stents provide mechanical support to maintain vascular patency; The drug coating releases everolimus, inhibits vascular intimal hyperplasia, and reduces the possibility of vascular restenosis.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Everolimus Eluting Stent leading manufacturers including Boston Scientific, Abbott, etc., dominate supply; the top five capture approximately % of global revenue, with Boston Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Everolimus Eluting Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Everolimus Eluting Stent Market Report

Report Metric Details
Report Name Everolimus Eluting Stent Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Abbott
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Everolimus Eluting Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Everolimus Eluting Stent Market report?

Ans: The main players in the Everolimus Eluting Stent Market are Boston Scientific, Abbott

What are the Application segmentation covered in the Everolimus Eluting Stent Market report?

Ans: The Applications covered in the Everolimus Eluting Stent Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Everolimus Eluting Stent Market report?

Ans: The Types covered in the Everolimus Eluting Stent Market report are PLGA Polymer Coating, Fluoropolymer Coating

Recommended Reports

Coronary Stent Markets

Peripheral & Specialty Stents

Vascular & Device Stents

1 Study Coverage
1.1 Introduction to Everolimus Eluting Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Everolimus Eluting Stent Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 PLGA Polymer Coating
1.2.3 Fluoropolymer Coating
1.3 Market Segmentation by Application
1.3.1 Global Everolimus Eluting Stent Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Everolimus Eluting Stent Revenue Estimates and Forecasts 2020-2031
2.2 Global Everolimus Eluting Stent Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Everolimus Eluting Stent Sales Estimates and Forecasts 2020-2031
2.4 Global Everolimus Eluting Stent Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Everolimus Eluting Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Everolimus Eluting Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 PLGA Polymer Coating Market Size by Manufacturers
3.6 Global Everolimus Eluting Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Everolimus Eluting Stent Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Everolimus Eluting Stent Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Everolimus Eluting Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Everolimus Eluting Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Everolimus Eluting Stent Sales and Revenue by Type (2020-2031)
6.4 North America Everolimus Eluting Stent Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Everolimus Eluting Stent Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Everolimus Eluting Stent Sales and Revenue by Type (2020-2031)
7.4 Europe Everolimus Eluting Stent Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Everolimus Eluting Stent Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Everolimus Eluting Stent Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Everolimus Eluting Stent Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Everolimus Eluting Stent Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Everolimus Eluting Stent Sales and Revenue by Type (2020-2031)
9.4 Central and South America Everolimus Eluting Stent Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Everolimus Eluting Stent Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Everolimus Eluting Stent Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Everolimus Eluting Stent Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Everolimus Eluting Stent Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Everolimus Eluting Stent Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Everolimus Eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Everolimus Eluting Stent Sales by Product in 2024
11.1.6 Boston Scientific Everolimus Eluting Stent Sales by Application in 2024
11.1.7 Boston Scientific Everolimus Eluting Stent Sales by Geographic Area in 2024
11.1.8 Boston Scientific Everolimus Eluting Stent SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Everolimus Eluting Stent Product Models, Descriptions and Specifications
11.2.4 Abbott Everolimus Eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Everolimus Eluting Stent Sales by Product in 2024
11.2.6 Abbott Everolimus Eluting Stent Sales by Application in 2024
11.2.7 Abbott Everolimus Eluting Stent Sales by Geographic Area in 2024
11.2.8 Abbott Everolimus Eluting Stent SWOT Analysis
11.2.9 Abbott Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Everolimus Eluting Stent Industry Chain
12.2 Everolimus Eluting Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Everolimus Eluting Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Everolimus Eluting Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Everolimus Eluting Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Everolimus Eluting Stent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Boston Scientific
Abbott
List of Tables
 Table 1. Global Everolimus Eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Everolimus Eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Everolimus Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Everolimus Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Everolimus Eluting Stent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Everolimus Eluting Stent Sales by Region (2020-2025) & (K Units)
 Table 8. Global Everolimus Eluting Stent Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Everolimus Eluting Stent Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Everolimus Eluting Stent Sales Share by Manufacturers (2020-2025)
 Table 12. Global Everolimus Eluting Stent Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Everolimus Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Everolimus Eluting Stent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Everolimus Eluting Stent as of 2024)
 Table 16. Global Everolimus Eluting Stent Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Everolimus Eluting Stent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Everolimus Eluting Stent Manufacturing Base and Headquarters
 Table 19. Global Everolimus Eluting Stent Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Everolimus Eluting Stent Sales by Type (2020-2025) & (K Units)
 Table 23. Global Everolimus Eluting Stent Sales by Type (2026-2031) & (K Units)
 Table 24. Global Everolimus Eluting Stent Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Everolimus Eluting Stent Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Everolimus Eluting Stent ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Everolimus Eluting Stent Sales by Application (2020-2025) & (K Units)
 Table 29. Global Everolimus Eluting Stent Sales by Application (2026-2031) & (K Units)
 Table 30. Everolimus Eluting Stent High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Everolimus Eluting Stent Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Everolimus Eluting Stent Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Everolimus Eluting Stent ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Everolimus Eluting Stent Growth Accelerators and Market Barriers
 Table 37. North America Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Everolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Everolimus Eluting Stent Growth Accelerators and Market Barriers
 Table 40. Europe Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Everolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Everolimus Eluting Stent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Everolimus Eluting Stent Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Everolimus Eluting Stent Investment Opportunities and Key Challenges
 Table 47. Central and South America Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Everolimus Eluting Stent Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Boston Scientific Corporation Information
 Table 51. Boston Scientific Description and Major Businesses
 Table 52. Boston Scientific Product Models, Descriptions and Specifications
 Table 53. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Boston Scientific Sales Value Proportion by Product in 2024
 Table 55. Boston Scientific Sales Value Proportion by Application in 2024
 Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. Boston Scientific Everolimus Eluting Stent SWOT Analysis
 Table 58. Boston Scientific Recent Developments
 Table 59. Abbott Corporation Information
 Table 60. Abbott Description and Major Businesses
 Table 61. Abbott Product Models, Descriptions and Specifications
 Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abbott Sales Value Proportion by Product in 2024
 Table 64. Abbott Sales Value Proportion by Application in 2024
 Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 66. Abbott Everolimus Eluting Stent SWOT Analysis
 Table 67. Abbott Recent Developments
 Table 68. Key Raw Materials Distribution
 Table 69. Raw Materials Key Suppliers
 Table 70. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 71. Milestones in Production Technology Evolution
 Table 72. Distributors List
 Table 73. Market Trends and Market Evolution
 Table 74. Market Drivers and Opportunities
 Table 75. Market Challenges, Risks, and Restraints
 Table 76. Research Programs/Design for This Report
 Table 77. Key Data Information from Secondary Sources
 Table 78. Key Data Information from Primary Sources


List of Figures
 Figure 1. Everolimus Eluting Stent Product Picture
 Figure 2. Global Everolimus Eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. PLGA Polymer Coating Product Picture
 Figure 4. Fluoropolymer Coating Product Picture
 Figure 5. Global Everolimus Eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Others
 Figure 9. Everolimus Eluting Stent Report Years Considered
 Figure 10. Global Everolimus Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Everolimus Eluting Stent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Everolimus Eluting Stent Revenue Market Share by Region (2020-2031)
 Figure 14. Global Everolimus Eluting Stent Sales (2020-2031) & (K Units)
 Figure 15. Global Everolimus Eluting Stent Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Everolimus Eluting Stent Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Everolimus Eluting Stent Sales Volume Market Share in 2024
 Figure 18. Global Everolimus Eluting Stent Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. PLGA Polymer Coating Revenue Market Share by Manufacturer in 2024
 Figure 21. Fluoropolymer Coating Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Everolimus Eluting Stent Sales Market Share by Type (2020-2031)
 Figure 23. Global Everolimus Eluting Stent Revenue Market Share by Type (2020-2031)
 Figure 24. Global Everolimus Eluting Stent Sales Market Share by Application (2020-2031)
 Figure 25. Global Everolimus Eluting Stent Revenue Market Share by Application (2020-2031)
 Figure 26. North America Everolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Everolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Everolimus Eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 29. North America Everolimus Eluting Stent Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Everolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Everolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Everolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Everolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Everolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Everolimus Eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Everolimus Eluting Stent Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Everolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Everolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Everolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 44. France Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Everolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Everolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Everolimus Eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Everolimus Eluting Stent Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Everolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Everolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Everolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 59. India Everolimus Eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Everolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Everolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Everolimus Eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Everolimus Eluting Stent Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Everolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Everolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Everolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Everolimus Eluting Stent Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Everolimus Eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Everolimus Eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Everolimus Eluting Stent Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Everolimus Eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Everolimus Eluting Stent Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Everolimus Eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Everolimus Eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 80. Everolimus Eluting Stent Industry Chain Mapping
 Figure 81. Regional Everolimus Eluting Stent Manufacturing Base Distribution (%)
 Figure 82. Global Everolimus Eluting Stent Production Market Share by Region (2020-2031)
 Figure 83. Everolimus Eluting Stent Production Process
 Figure 84. Regional Everolimus Eluting Stent Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Sirolimus Eluting Stent Market Research Report 2024
Global Sirolimus Coated Stent Market Research Report 2024
Global Sirolimus Eluting Coronary Stent Market Research Report 2025
Global Peripheral Drug Eluting Stent Market Research Report 2025
Global Rapamycin Coated Stent Market Research Report 2024
Global Next Generation Drug Eluting Stent Market Research Report 2024
Global Drug Eluting Coronary Stent Market Research Report 2025
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Drug Eluting Guidewire Market Research Report 2024
Global Drug Coated Stent System Market Research Report 2024
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Global Metal Esophageal Stent Market Research Report 2024
Global Mg Alloy Vascular Scaffold Market Research Report 2024
Metal Neurovascular Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bioabsorbable Eluting Coronary Stent System Market Research Report 2024
Global Bioresorbable Drug Eluting Stents Market Research Report 2025
Global Abdominal Aortic Covered Stents Market Research Report 2024
Global Peripheral Stents Market Research Report 2024
Global Biodegradable Drug Eluting Stents Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions